AM 374
CAS No. 86855-26-7
AM 374( —— )
Catalog No. M36258 CAS No. 86855-26-7
AM 374 (HDSF), a fatty acid amide hydrolase (FAAH) inhibitor, demonstrates the capacity to inhibit amidase activity, boasting an IC50 value of 13 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 41 | In Stock |
|
| 5MG | 37 | In Stock |
|
| 10MG | 64 | In Stock |
|
| 25MG | 131 | In Stock |
|
| 50MG | 206 | In Stock |
|
| 100MG | 305 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAM 374
-
NoteResearch use only, not for human use.
-
Brief DescriptionAM 374 (HDSF), a fatty acid amide hydrolase (FAAH) inhibitor, demonstrates the capacity to inhibit amidase activity, boasting an IC50 value of 13 nM.
-
DescriptionAM 374 is an fatty acid amide hydrolase (FAAH) inhibitor. AM 374 inhibits amidase activity with an IC50 value of 13 nM. AM 374 can be used for the research of neurological disease.
-
In Vitro——
-
In VivoAnimal Model:Adult male Sprague-Dawley rats with lever press training Dosage:20 μg Administration:Intraventricular (ICV) injection; 20 μg, once Result:Significantly reduced lever pressing when combined treatment with anandamide.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetFAAH
-
RecptorFAAH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number86855-26-7
-
Formula Weight308.5
-
Molecular FormulaC16H33FO2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (324.15 mM; Ultrasonic )
-
SMILESCCCCCCCCCCCCCCCCS(F)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Deutsch DG, et al. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. Biochem Biophys Res Commun. 1997 Feb 3;231(1):217-21.?
molnova catalog
related products
-
VU534
VU534 is a NAPE-PLD agonist with an EC50 of 0.30 μM.VU534 is a dual inhibitor of FAAH and sEH, with an IC50 of 1.2 μM for sEH.VU534 is used in diseases related to cardiometabolism.
-
PDP-EA
PDP-EA is an activator of fatty acid amide hydrolase(FAAH) and enhances the amidohydrolase activity of FAAH.
-
N-(3-Methoxybenzyl)P...
N-(3-Methoxybenzyl)Palmitamide is a promising FAAH inhibitor, treatment of pain, inflammation and CNS degenerative disorders.
Cart
sales@molnova.com